We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Neurons Grown from Skin Cells May Hold Clues to Autism

By LabMedica International staff writers
Posted on 28 Dec 2011
Potential insights into how autism disrupts the brain are emerging from research into a rare genetic form of the disorders that affects fewer than 20 individuals worldwide. More...
Using a groundbreaking “disease-in a-dish” technique, researchers have grown patients’ skin cells into neurons to discover what goes wrong in the brain in Timothy syndrome.

Affected children with this disorder frequently show symptoms of autism spectrum disorders combined with a constellation of physical problems. Abnormalities included changes in the composition of cells in the cortex, the largest brain structure in humans, and of neurons that secrete two key chemical messengers. Neurons that make long-distance connections between the brain’s hemispheres tended to be in short supply.

Most patients with Timothy syndrome meet diagnostic criteria for an autism spectrum disorder. However, unlike most cases of autism, Timothy syndrome is known to be caused by a single genetic mutation. “Studying the consequences of a single mutation, compared to multiple genes with small effects, vastly simplifies the task of pinpointing causal mechanisms,” explained Ricardo Dolmetsch, PhD, from Stanford University (Stanford, CA, USA), a US National Institute of Mental Health (NIMH; Bethesda, MD, USA) grantee who led the study.

Dr. Dolmetsch, and colleagues, reported on their findings November 27, 2011, in the journal Nature Medicine. “Unlike animal research, the cutting-edge technology employed in this study makes it possible to pinpoint molecular defects in a patient’s own brain cells,” said NIMH director Thomas R. Insel, MD. “It also offers a way to screen more rapidly for medications that act on the disordered process.”

Before this research, researchers knew that Timothy syndrome is caused by a tiny malfunction in the gene which codes for a calcium channel protein in cell membranes. The mutation results in too much calcium entering cells, causing a characteristic set of abnormalities throughout the body. Accurate functioning of the calcium channel is known to be particularly critical for proper heart rhythm--many patients die in childhood of arrhythmias--but its role in brain cells was less well understood.

To understand more, Dr. Dolmetsch and colleagues used a new technology called induced pluripotent stem cells (iPSCs). They first transformed skin cells from Timothy syndrome patients into stem cells and then coaxed these to differentiate into neurons.

“Remarkable reproducibility” observed across multiple iPSC lines and individuals validated that the technique can reveal defects in neuronal differentiation--such as whether cells assume the correct identity as the brain gets wired-up in early development, said the researchers. Compared to those from controls, fewer neurons from Timothy syndrome patients became neurons of the lower layers of the cortex and more became upper layer neurons. The lower layer cells that remained were more likely to be the sort that project to areas below the cortex. In comparison, there were fewer-than-normal neurons equipped to form a structure, called the corpus callosum, which makes possible communications between the left and right hemispheres.

Many of these defects were also seen in equivalent studies of mice with the same genetic mutation found in Timothy syndrome patients. This supports the link between the mutation and the developmental abnormalities.

Several genes earlier implicated in autism were among hundreds found to be expressed abnormally in Timothy syndrome neurons. Excess cellular calcium levels also caused an overproduction of neurons that make key chemical messengers. Timothy syndrome neurons secreted 3.5 times more norepinephrine and 2.3 times more dopamine than control neurons. Addition of a drug that blocks the calcium channel reversed the abnormalities in cultured neurons, reducing the proportion of catecholamine-secreting cells by 68%.

The findings in Timothy syndrome patient iPSCs follow those in Rett syndrome, another single gene disorder that frequently includes autism-like symptoms. About one year ago, Alysson Muotri, PhD, and colleagues at University of California, San Diego (USA), reported deficits in the protrusions of neurons, called spines, which help form connections, or synapses. The scientists’ discovery of earlier (neuronal fate) and later (altered connectivity) defects suggest that disorders on the autism spectrum affect multiple stages in early brain development.

“Most of these abnormalities are consistent with other emerging evidence that ASDs arise from defects in connectivity between cortex areas and show decreased size of the corpus callosum,” concluded Dr. Dolmetsch. “Our study reveals how these might be traceable to specific mechanisms set in motion by poor regulation of cellular calcium. It also demonstrates that neurons derived from iPSCs can be used to identify the cellular basis of a neurodevelopmental disorder.”

The processes identified in this study may become potential targets for developing new therapies for Timothy Syndrome and may also provide insights into the neural basis of deficits in other forms of autism, according to Dr. Dolmetsch.

Related Links:
Stanford University
National Institute of Mental Health


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.